__________________________________________________________________________________________
30/JUN/2014
Re: Local ID TH140104729 / TH201405006736 FU (1)
Thank you for reporting to us an adverse event related to Lilly product.
We would like to collect more information to better understanding the reported event.
Please respond to following questions regarding the adverse event – a bulge in patient’s collar bone, involving a female patient who was subscribed Forteo, reported the event to Lilly on 22/JAN/2014.
Please ask caregiver to provide HCP contact information. If obtained, please ask HCP:
1. Please provide a diagnosis for the event.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
2. Results of imaging studies if performed
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
3. Please provide date when the event appeared.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
4. Please provide Forteo start date.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
5. Was the event related to Forteo? Please provide rationale.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
6. Did patient receive any corrective treatment? If so, please mention it.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
7. Current outcome of the event
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Thanks
Yours sincerely,
ELI LILLY AND COMPANY
Sasithorn Suntharo
Pharmacovigilance Associate
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: